Literature DB >> 15136669

Clinical and histologic findings in autosomal centronuclear myopathy.

P-Y Jeannet1, G Bassez, B Eymard, P Laforêt, J A Urtizberea, A Rouche, P Guicheney, M Fardeau, N B Romero.   

Abstract

Centronuclear myopathy (CNM) is a congenital myopathy characterized by chains of centrally located nuclei in a large number of muscle fibers. Clinically, an early-onset form was reported in several autosomal-recessive (AR) families and many sporadic patients, whereas a late-onset form was found in most autosomal-dominant (AD) families. The boundary between these two forms remains unclear, and the molecular basis of autosomal CNM is still unresolved. To better define the clinical and morphologic characteristics of autosomal CNM, the authors analyzed a series of 29 patients from 12 families. Two subgroups were identified in three AD families: two families had a relatively late onset of disease and a slow progression of diffuse weakness, whereas the third family, who had a similar clinical course, also presented a unique diffuse muscle hypertrophy. Two presumed AR families and seven sporadic patients were analyzed together, and three subgroups were identified: 1) an early-onset form with ophthalmoparesis; 2) an early-onset form without ophthalmoparesis; and 3) a late-onset form without ophthalmoparesis. Overall, 23 muscle biopsies were reviewed; a majority of patients had >20% central nuclei, fiber type 1 predominance, and a radial distribution of sarcoplasmic strands on oxidative stains. A marked endomysial fibrosis was observed in three sporadic patients with a relatively severe clinical course. The classification reported in this study will be useful for the diagnosis and the follow-up evaluation of patients with autosomal CNM and for the research into the molecular defects underlying the condition.

Entities:  

Mesh:

Year:  2004        PMID: 15136669     DOI: 10.1212/01.wnl.0000124388.67003.56

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

1.  Severe phenotype of a patient with autosomal recessive centronuclear myopathy due to a BIN1 mutation.

Authors:  A Y Mejaddam; I Nennesmo; T Sejersen
Journal:  Acta Myol       Date:  2009-12

2.  Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2.

Authors:  Osamu Nakagawa; Michael Arnold; Masayo Nakagawa; Hideaki Hamada; John M Shelton; Hajime Kusano; Thomas M Harris; Geoffrey Childs; Kevin P Campbell; James A Richardson; Ichizo Nishino; Eric N Olson
Journal:  Genes Dev       Date:  2005-09-01       Impact factor: 11.361

3.  Sporadic centronuclear myopathy with muscle pseudohypertrophy, neutropenia, and necklace fibers due to a DNM2 mutation.

Authors:  Teerin Liewluck; Tracy L Lovell; Anna V Bite; Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2010-12       Impact factor: 4.296

Review 4.  Muscle biopsy evaluation in neuromuscular disorders.

Authors:  Nanette C Joyce; Björn Oskarsson; Lee-Way Jin
Journal:  Phys Med Rehabil Clin N Am       Date:  2012-08       Impact factor: 1.784

Review 5.  Dynamin 2 and human diseases.

Authors:  Anne-Cécile Durieux; Bernard Prudhon; Pascale Guicheney; Marc Bitoun
Journal:  J Mol Med (Berl)       Date:  2010-02-03       Impact factor: 4.599

6.  Clinical and Pathological Features of Korean Patients with DNM2-Related Centronuclear Myopathy.

Authors:  Young-Eun Park; Young-Chul Choi; Jong-Suk Bae; Chang-Hoon Lee; Hyang-Suk Kim; Jin-Hong Shin; Dae-Seong Kim
Journal:  J Clin Neurol       Date:  2014-01-06       Impact factor: 3.077

7.  Autosomal dominant centronuclear myopathy with unique clinical presentations.

Authors:  Jee Young Lee; Ju Hong Min; Yoon Ho Hong; Jung Joon Sung; Sung Hye Park; Seong Ho Park; Kwang Woo Lee; Kyung Seok Park
Journal:  J Korean Med Sci       Date:  2007-12       Impact factor: 2.153

Review 8.  Case report of intrafamilial variability in autosomal recessive centronuclear myopathy associated to a novel BIN1 stop mutation.

Authors:  Johann Böhm; Uluç Yiş; Ragıp Ortaç; Handan Cakmakçı; Semra Hız Kurul; Eray Dirik; Jocelyn Laporte
Journal:  Orphanet J Rare Dis       Date:  2010-12-03       Impact factor: 4.123

9.  Mild functional differences of dynamin 2 mutations associated to centronuclear myopathy and Charcot-Marie Tooth peripheral neuropathy.

Authors:  Olga S Koutsopoulos; Catherine Koch; Valerie Tosch; Johann Böhm; Kathryn N North; Jocelyn Laporte
Journal:  PLoS One       Date:  2011-11-11       Impact factor: 3.240

10.  Centronuclear myopathy related to dynamin 2 mutations: clinical, morphological, muscle imaging and genetic features of an Italian cohort.

Authors:  Michela Catteruccia; Fabiana Fattori; Valentina Codemo; Lucia Ruggiero; Lorenzo Maggi; Giorgio Tasca; Chiara Fiorillo; Marika Pane; Angela Berardinelli; Margherita Verardo; Cinzia Bragato; Marina Mora; Lucia Morandi; Claudio Bruno; Lucio Santoro; Elena Pegoraro; Eugenio Mercuri; Enrico Bertini; Adele D'Amico
Journal:  Neuromuscul Disord       Date:  2013-02-08       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.